PDB Short entry for 2XA0 HEADER APOPTOSIS 25-MAR-10 2XA0 TITLE CRYSTAL STRUCTURE OF BCL-2 IN COMPLEX WITH A BAX BH3 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOPTOSIS REGULATOR BCL-2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 1-207; COMPND 5 SYNONYM: BCL-2; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: APOPTOSIS REGULATOR BAX; COMPND 9 CHAIN: C, D; COMPND 10 FRAGMENT: BH3 DOMAIN, RESIDUES 52-82; COMPND 11 SYNONYM: BAX; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)RIG; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PPROEX HTA; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 13 ORGANISM_COMMON: MOUSE; SOURCE 14 ORGANISM_TAXID: 10090 KEYWDS APOPTOSIS, CELL DEATH EXPDTA X-RAY DIFFRACTION AUTHOR B.KU,B.H.OH REVDAT 3 20-DEC-23 2XA0 1 REMARK REVDAT 2 01-JUN-11 2XA0 1 JRNL REVDAT 1 24-NOV-10 2XA0 0 JRNL AUTH B.KU,C.LIANG,J.U.JUNG,B.H.OH JRNL TITL EVIDENCE THAT INHIBITION OF BAX ACTIVATION BY BCL- 2 JRNL TITL 2 INVOLVES ITS TIGHT AND PREFERENTIAL INTERACTION WITH THE BH3 JRNL TITL 3 DOMAIN OF BAX. JRNL REF CELL RES. V. 21 627 2011 JRNL REFN ISSN 1001-0602 JRNL PMID 21060336 JRNL DOI 10.1038/CR.2010.149 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.1 REMARK 3 NUMBER OF REFLECTIONS : 14476 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 708 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2712 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 21 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.22200 REMARK 3 B22 (A**2) : -0.22200 REMARK 3 B33 (A**2) : 0.44300 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.363 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 44.81 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES 35-50 OF BCL-2 ARE REPLACED REMARK 3 WITH RESIDUES 33-48 OF BCL-XL TO SOLUBILIZE THE PROTEIN AS REMARK 3 REPORTED EARLIER (PETROS ET AL, PROC NATL ACAD SCI U S A 98, REMARK 3 3012-3017(2001)) . HOWEVER, THE FINAL MODEL DOES NOT INCLUDE THE REMARK 3 ENTIRE BCL- XL SUBSTITUTION REGION, WHOSE ELECTRON DENSITIES REMARK 3 WERE NOT OBSERVED. REMARK 4 REMARK 4 2XA0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-MAR-10. REMARK 100 THE DEPOSITION ID IS D_1290043418. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14540 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.9 REMARK 200 DATA REDUNDANCY : 9.700 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 30.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 75.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.22000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1G5M REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM ACETATE (PH 4.2), 3.0 M REMARK 280 SODIUM FORMATE REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 46.28333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 92.56667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 92.56667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 46.28333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2230 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8290 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.3 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 HIS A 3 REMARK 465 ALA A 4 REMARK 465 GLY A 5 REMARK 465 ARG A 6 REMARK 465 THR A 7 REMARK 465 GLY A 8 REMARK 465 TYR A 9 REMARK 465 ALA A 32 REMARK 465 GLY A 33 REMARK 465 ASP A 34 REMARK 465 VAL A 35 REMARK 465 GLY A 36 REMARK 465 ALA A 37 REMARK 465 ALA A 38 REMARK 465 PRO A 39 REMARK 465 PRO A 40 REMARK 465 GLY A 41 REMARK 465 ALA A 42 REMARK 465 ALA A 43 REMARK 465 PRO A 44 REMARK 465 ALA A 45 REMARK 465 PRO A 46 REMARK 465 GLY A 47 REMARK 465 ILE A 48 REMARK 465 PHE A 49 REMARK 465 SER A 50 REMARK 465 SER A 51 REMARK 465 GLN A 52 REMARK 465 PRO A 53 REMARK 465 GLY A 54 REMARK 465 HIS A 55 REMARK 465 THR A 56 REMARK 465 PRO A 57 REMARK 465 HIS A 58 REMARK 465 PRO A 59 REMARK 465 ALA A 60 REMARK 465 ALA A 61 REMARK 465 SER A 62 REMARK 465 ARG A 63 REMARK 465 ASP A 64 REMARK 465 PRO A 65 REMARK 465 VAL A 66 REMARK 465 ALA A 67 REMARK 465 ARG A 68 REMARK 465 THR A 69 REMARK 465 SER A 70 REMARK 465 PRO A 71 REMARK 465 LEU A 72 REMARK 465 GLN A 73 REMARK 465 THR A 74 REMARK 465 PRO A 75 REMARK 465 ALA A 76 REMARK 465 ALA A 77 REMARK 465 PRO A 78 REMARK 465 GLY A 79 REMARK 465 ALA A 80 REMARK 465 ALA A 81 REMARK 465 ALA A 82 REMARK 465 GLY A 83 REMARK 465 PRO A 84 REMARK 465 ALA A 85 REMARK 465 LEU A 86 REMARK 465 SER A 87 REMARK 465 PRO A 88 REMARK 465 VAL A 89 REMARK 465 PRO A 90 REMARK 465 PRO A 91 REMARK 465 ARG A 207 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 HIS B 3 REMARK 465 ALA B 4 REMARK 465 GLY B 5 REMARK 465 ARG B 6 REMARK 465 THR B 7 REMARK 465 GLY B 8 REMARK 465 TYR B 9 REMARK 465 ALA B 32 REMARK 465 GLY B 33 REMARK 465 ASP B 34 REMARK 465 VAL B 35 REMARK 465 GLY B 36 REMARK 465 ALA B 37 REMARK 465 ALA B 38 REMARK 465 PRO B 39 REMARK 465 PRO B 40 REMARK 465 GLY B 41 REMARK 465 ALA B 42 REMARK 465 ALA B 43 REMARK 465 PRO B 44 REMARK 465 ALA B 45 REMARK 465 PRO B 46 REMARK 465 GLY B 47 REMARK 465 ILE B 48 REMARK 465 PHE B 49 REMARK 465 SER B 50 REMARK 465 SER B 51 REMARK 465 GLN B 52 REMARK 465 PRO B 53 REMARK 465 GLY B 54 REMARK 465 HIS B 55 REMARK 465 THR B 56 REMARK 465 PRO B 57 REMARK 465 HIS B 58 REMARK 465 PRO B 59 REMARK 465 ALA B 60 REMARK 465 ALA B 61 REMARK 465 SER B 62 REMARK 465 ARG B 63 REMARK 465 ASP B 64 REMARK 465 PRO B 65 REMARK 465 VAL B 66 REMARK 465 ALA B 67 REMARK 465 ARG B 68 REMARK 465 THR B 69 REMARK 465 SER B 70 REMARK 465 PRO B 71 REMARK 465 LEU B 72 REMARK 465 GLN B 73 REMARK 465 THR B 74 REMARK 465 PRO B 75 REMARK 465 ALA B 76 REMARK 465 ALA B 77 REMARK 465 PRO B 78 REMARK 465 GLY B 79 REMARK 465 ALA B 80 REMARK 465 ALA B 81 REMARK 465 ALA B 82 REMARK 465 GLY B 83 REMARK 465 PRO B 84 REMARK 465 ALA B 85 REMARK 465 LEU B 86 REMARK 465 SER B 87 REMARK 465 PRO B 88 REMARK 465 VAL B 89 REMARK 465 PRO B 90 REMARK 465 PRO B 91 REMARK 465 ARG B 207 REMARK 465 GLN C 52 REMARK 465 ASP C 53 REMARK 465 ALA C 54 REMARK 465 SER C 55 REMARK 465 THR C 56 REMARK 465 GLN D 52 REMARK 465 ASP D 53 REMARK 465 ALA D 54 REMARK 465 SER D 55 REMARK 465 THR D 56 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR A 28 OD1 ASN A 163 1.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 THR B 122 N - CA - C ANGL. DEV. = -17.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 25 -3.17 -56.73 REMARK 500 GLU A 114 133.60 -35.48 REMARK 500 MET A 166 33.12 -148.96 REMARK 500 PRO A 204 7.88 -63.14 REMARK 500 ARG B 109 23.96 -76.48 REMARK 500 MET B 166 43.17 -156.33 REMARK 500 THR B 187 -74.92 -51.31 REMARK 500 PRO B 204 7.36 -63.60 REMARK 500 ALA C 81 10.00 -58.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1YSW RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-2COMPLEXED REMARK 900 WITH AN ACYL- SULFONAMIDE-BASED LIGAND REMARK 900 RELATED ID: 2W3L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHIMAERIC BCL2-XL AND PHENYL REMARK 900 TETRAHYDROISOQUINOLINE AMIDE COMPLEX REMARK 900 RELATED ID: 1G5M RELATED DB: PDB REMARK 900 HUMAN BCL-2, ISOFORM 1 REMARK 900 RELATED ID: 1GJH RELATED DB: PDB REMARK 900 HUMAN BCL-2, ISOFORM 2 DBREF 2XA0 A 1 207 UNP P10415 BCL2_HUMAN 1 207 DBREF 2XA0 B 1 207 UNP P10415 BCL2_HUMAN 1 207 DBREF 2XA0 C 52 82 UNP Q07813 BAX_MOUSE 52 82 DBREF 2XA0 D 52 82 UNP Q07813 BAX_MOUSE 52 82 SEQRES 1 A 207 MET ALA HIS ALA GLY ARG THR GLY TYR ASP ASN ARG GLU SEQRES 2 A 207 ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SER GLN ARG SEQRES 3 A 207 GLY TYR GLU TRP ASP ALA GLY ASP VAL GLY ALA ALA PRO SEQRES 4 A 207 PRO GLY ALA ALA PRO ALA PRO GLY ILE PHE SER SER GLN SEQRES 5 A 207 PRO GLY HIS THR PRO HIS PRO ALA ALA SER ARG ASP PRO SEQRES 6 A 207 VAL ALA ARG THR SER PRO LEU GLN THR PRO ALA ALA PRO SEQRES 7 A 207 GLY ALA ALA ALA GLY PRO ALA LEU SER PRO VAL PRO PRO SEQRES 8 A 207 VAL VAL HIS LEU THR LEU ARG GLN ALA GLY ASP ASP PHE SEQRES 9 A 207 SER ARG ARG TYR ARG ARG ASP PHE ALA GLU MET SER SER SEQRES 10 A 207 GLN LEU HIS LEU THR PRO PHE THR ALA ARG GLY ARG PHE SEQRES 11 A 207 ALA THR VAL VAL GLU GLU LEU PHE ARG ASP GLY VAL ASN SEQRES 12 A 207 TRP GLY ARG ILE VAL ALA PHE PHE GLU PHE GLY GLY VAL SEQRES 13 A 207 MET CYS VAL GLU SER VAL ASN ARG GLU MET SER PRO LEU SEQRES 14 A 207 VAL ASP ASN ILE ALA LEU TRP MET THR GLU TYR LEU ASN SEQRES 15 A 207 ARG HIS LEU HIS THR TRP ILE GLN ASP ASN GLY GLY TRP SEQRES 16 A 207 ASP ALA PHE VAL GLU LEU TYR GLY PRO SER MET ARG SEQRES 1 B 207 MET ALA HIS ALA GLY ARG THR GLY TYR ASP ASN ARG GLU SEQRES 2 B 207 ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SER GLN ARG SEQRES 3 B 207 GLY TYR GLU TRP ASP ALA GLY ASP VAL GLY ALA ALA PRO SEQRES 4 B 207 PRO GLY ALA ALA PRO ALA PRO GLY ILE PHE SER SER GLN SEQRES 5 B 207 PRO GLY HIS THR PRO HIS PRO ALA ALA SER ARG ASP PRO SEQRES 6 B 207 VAL ALA ARG THR SER PRO LEU GLN THR PRO ALA ALA PRO SEQRES 7 B 207 GLY ALA ALA ALA GLY PRO ALA LEU SER PRO VAL PRO PRO SEQRES 8 B 207 VAL VAL HIS LEU THR LEU ARG GLN ALA GLY ASP ASP PHE SEQRES 9 B 207 SER ARG ARG TYR ARG ARG ASP PHE ALA GLU MET SER SER SEQRES 10 B 207 GLN LEU HIS LEU THR PRO PHE THR ALA ARG GLY ARG PHE SEQRES 11 B 207 ALA THR VAL VAL GLU GLU LEU PHE ARG ASP GLY VAL ASN SEQRES 12 B 207 TRP GLY ARG ILE VAL ALA PHE PHE GLU PHE GLY GLY VAL SEQRES 13 B 207 MET CYS VAL GLU SER VAL ASN ARG GLU MET SER PRO LEU SEQRES 14 B 207 VAL ASP ASN ILE ALA LEU TRP MET THR GLU TYR LEU ASN SEQRES 15 B 207 ARG HIS LEU HIS THR TRP ILE GLN ASP ASN GLY GLY TRP SEQRES 16 B 207 ASP ALA PHE VAL GLU LEU TYR GLY PRO SER MET ARG SEQRES 1 C 31 GLN ASP ALA SER THR LYS LYS LEU SER GLU CYS LEU ARG SEQRES 2 C 31 ARG ILE GLY ASP GLU LEU ASP SER ASN MET GLU LEU GLN SEQRES 3 C 31 ARG MET ILE ALA ASP SEQRES 1 D 31 GLN ASP ALA SER THR LYS LYS LEU SER GLU CYS LEU ARG SEQRES 2 D 31 ARG ILE GLY ASP GLU LEU ASP SER ASN MET GLU LEU GLN SEQRES 3 D 31 ARG MET ILE ALA ASP FORMUL 5 HOH *21(H2 O) HELIX 1 1 ASN A 11 ARG A 26 1 16 HELIX 2 2 VAL A 93 PHE A 112 1 20 HELIX 3 3 MET A 115 GLN A 118 5 4 HELIX 4 4 THR A 125 ARG A 139 1 15 HELIX 5 5 TRP A 144 ARG A 164 1 21 HELIX 6 6 PRO A 168 LEU A 185 1 18 HELIX 7 7 LEU A 185 ASN A 192 1 8 HELIX 8 8 TRP A 195 GLY A 203 1 9 HELIX 9 9 ASN B 11 ARG B 26 1 16 HELIX 10 10 VAL B 93 PHE B 112 1 20 HELIX 11 11 MET B 115 GLN B 118 5 4 HELIX 12 12 THR B 125 ARG B 139 1 15 HELIX 13 13 TRP B 144 ARG B 164 1 21 HELIX 14 14 PRO B 168 LEU B 185 1 18 HELIX 15 15 LEU B 185 ASN B 192 1 8 HELIX 16 16 TRP B 195 GLY B 203 1 9 HELIX 17 17 LEU C 59 ALA C 81 1 23 HELIX 18 18 LEU D 59 ALA D 81 1 23 CRYST1 81.973 81.973 138.850 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012199 0.007043 0.000000 0.00000 SCALE2 0.000000 0.014086 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007202 0.00000